Senseonics Holdings, a medical technology company focussed on the development and manufacturing of long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes, has received the CE mark for the Eversense NOW Remote Monitoring App for the Android Operating System.
Tim Goodnow, president and CEO of Senseonics, said: “We’re pleased to offer yet another tool for our Eversense users in Europe, now enabling access to this important feature for all our customers. With the Eversense NOW app, Eversense users can enjoy the added peace of mind that comes with knowing friends and family can remotely view real-time glucose data, see trend graphs, and receive real-time glucose alerts from anywhere.”
The Eversense NOW Remote Monitoring app for the Android operating system is expected to be available starting in the first quarter of 2022 on the Google Play Store.
